Company / Working Capital per Share
Royalty Pharma plc Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.48
FY2025
5-year range
$1.25 / $7.21
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
#168 of 210
Health Care
What the data says
Royalty Pharma plc's working capital per share of $1.48 is lower than 80% of companies in the Health Care sector (FY2025). Working Capital per Share returned to growth in FY2025 after 3 years of decline, reaching $1.48.
Based on SEC 10-K filings.
1.48 in FY2025 with a 5-year CAGR of -25.3%.
Declined from $2.68 to $1.48 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -26.3%
- 5-Year CAGR
- -25.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 210This company $1.48 Sector average $118.60
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 18.1% year-over-year.
- Ranks #168 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.48 | +18.1% |
| FY2024 | $1.25 | -53.3% |
| FY2023 | $2.68 | -27.4% |
| FY2022 | $3.70 | -48.7% |
| FY2021 | $7.21 | +13.3% |
| FY2020 | $6.36 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026